NCT03652779View on ClinicalTrials.gov

A Study to Evaluate the Safety and Tolerability of Tecarfarin in Healthy Chinese Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 22, 2018

Primary Completion Date

October 28, 2019

Study Completion Date

October 28, 2019

Conditions
Pharmacokinetic and Pharmacodynamic Profile of Tecarfarin
Interventions
DRUG

Tecarfarin 10mg

Tecarfarin 10mg tablets

DRUG

Tecarfarin 20mg

two tecarfarin 10mg tablets

DRUG

Tecarfarin 30mg

three tecarfarin 10mg tablets

DRUG

Tecarfarin 40mg

four tecarfarin 10mg tablets

Trial Locations (1)

000000

HKU Phase 1 Clinical Trial Centre, The University of Hong Kong, Hong Kong

Sponsors
All Listed Sponsors
lead

Lee's Pharmaceutical Limited

INDUSTRY